Your idea: Nifty Change of character & Break of structure on the change of charac…
One-time — gone on refresh. Copy it and paste as a YouTube comment.
Detected components (auto-read from transcript)
Verdict
Real option-buying backtest. Decoded entry: price crossing its EMA on NIFTY 10-min bars → buy the ATM weekly CE (long) / PE (short), stop 30% / target 60% of premium, square-off by 15:15. Priced on real 1-minute NIFTY option premiums (GFDL, 2015–2026 — every tick of theta, IV crush and gamma is inside these prices), real charges and spread.
12,849 trades on ₹1L: net -1336.7% over 12 years (-111.4%/yr, loses money), win 40%, payoff 1.36 (avg win ₹2,152 / avg loss ₹-1,579), max drawdown -1408%, worst trade ₹-11,518. 2015: ₹-57,390. 2016: ₹-126,409. 2017: ₹-90,345. 2018: ₹-68,493. 2019: ₹-111,893. 2020: ₹-193,504. 2021: ₹-67,786. 2022: ₹-174,395. 2023: ₹-128,074. 2024: ₹-132,621. 2025: ₹-235,007. 2026: ₹+49,217.
Option buying is convex — low win-rates are normal; the question is whether winners outrun the premium bleed. Backtested on 12 years of minute-level premium data (2015–2026; monthly contracts before 2019 — weeklies didn't exist; constant 65-unit lot); entries tested intraday as taught. Flagged for human review.
Is it profitable? (green above the line = made money, red below = lost it)
Year by year (every trade the rules fired, on real NIFTY option premiums — 1 lot, ₹1L)
| Year | Trades | Win % | Net P&L |
|---|---|---|---|
| 2015 | 507 | 39% | ₹-57,390 |
| 2016 | 847 | 40% | ₹-126,409 |
| 2017 | 1023 | 41% | ₹-90,345 |
| 2018 | 939 | 42% | ₹-68,493 |
| 2019 | 1007 | 37% | ₹-111,893 |
| 2020 | 1059 | 39% | ₹-193,504 |
| 2021 | 1568 | 41% | ₹-67,786 |
| 2022 | 1231 | 39% | ₹-174,395 |
| 2023 | 1255 | 38% | ₹-128,074 |
| 2024 | 1109 | 39% | ₹-132,621 |
| 2025 | 1649 | 39% | ₹-235,007 |
| 2026 | 655 | 42% | ₹+49,217 |
Full transcript (81 words)
💬 Trader reviews (traded this? tell others what really happened)
No reviews yet — be the first. Real experiences help other traders more than any backtest.
User opinions, not investment advice. Reviews are moderated before publishing.